Delivery Order SPE2DB22D1202-SPE2DB25FUPW5
Award Date
1/16/25
Potential Completion Date
1/17/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Copaxone 40 mg/mL syringes, a medication used to treat relapsing forms of multiple sclerosis. The contract has a ceiling value of $1,583.28 and a completion date of April 30, 2024. It is a firm-fixed-price delivery order contract, without any set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML syringes, a medication used to treat multiple sclerosis. The contract has a firm fixed price of $3,486.00 and a period of performance through October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE. The $1,055.54 delivery order, which does not have a set-aside designation, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,258.24, is a delivery order for the supply of Copaxone 40 mg/mL syringes, a specialty medication. The contract has a firm-fixed price pricing type and an ultimate completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract, SPE2DX15D3020|SPE2DX24FXMWX, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Copaxone 40 mg/ml syringes. The contract has a ceiling value of $3,126.39 and a performance period through March 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $4,749.84 and a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen), a major pharmaceutical distributor. The contract is for the supply of Copaxone 40 mg/mL syringes, a specialty medication. The delivery order has a ceiling value of $1,055.52 and a completion date of September 24, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of parent company Cencora, Inc. The contract is for the supply of COPAXONE 40 MG/ML syringes, a specialty pharmaceutical medication, with a potential value of $3,166.62 and a completion date of January 26, 2024. The contract is not set aside and is being issued as a standalone delivery order. Amerisourcebergen Drug Corp is the prime...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,241.53 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COPAXONE 40 MG/ML SYRINGEML medications. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...